Results 231 to 240 of about 393,600 (259)

Be vigilant for invasive meningococcal disease.

The Practitioner, 2014
Neisseria meningitidis is an encapsulated Gram-negative diplococcus which colonises the upper respiratory tract without causing symptoms in up to 25% of the population. At least 13 different serogroups cause invasive meningococcal disease (IND). In the UK serogroup B causes more than 80% of cases of invasive disease. More than 75% of cases occur in the
openaire   +1 more source

Inflammatory Breast Cancer: The Disease, the Biology, the Treatment

Ca-A Cancer Journal for Clinicians, 2010
Melissa L Bondy, Thomas Buchholz, Anthony Lucci   +2 more
exaly  

Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia

New England Journal of Medicine, 2020
Mark McMillan, Helen S Marshall, Caroline L Trotter   +2 more
exaly  

Progress and controversies: Radiation therapy for invasive breast cancer

Ca-A Cancer Journal for Clinicians, 2014
Reshma Jagsi
exaly  

Invasive meningococcal disease in Spain, 2024

Introducción: La enfermedad meningocócica invasiva (EMI) es una enfermedad infecciosa grave de declaración obligatoria. El objetivo es describir la epidemiología de la EMI en España en el año 2024 y compararla con años anteriores. Método: Análisis epidemiológico descriptivo de los casos de EMI notificados a la Red Nacional de Vigilancia Epidemiológica (
Masa Calles, Josefa, Martín Sánchez, Alexandra, del Águila Mejía, Javier, Acosta Gutiérrez , Marina, Soler Soneira, Marta, Cano Portero, Rosa   +5 more
openaire  

Invasive meningococcal disease in children

Forum Zakażeń, 2014
openaire   +1 more source

Invasive meningococcal disease presenting with cellulitis

Medical Journal of Australia, 2006
Karina J Kennedy, Jhumur Roy, Paul Lamberth   +2 more
openaire   +1 more source

Meningococcal group A, C, Y and W-135 conjugate vaccine

Nature Reviews Drug Discovery, 2010
Peter Kirkpatrick, Lee H Harrison
exaly  

[Prevention strategy for invasive meningococcal disease].

La Revue du praticien
PREVENTION STRATEGY FOR INVASIVE MENINGOCOCCAL DISEASE. The prevention strategy for invasive meningococcal disease (IMD) includes vaccination and antibiotic prophylaxis in the vicinity of a case. IMD is unpredictable, difficult to recognize at an early stage, and very severe, with a mortality rate about 10 %, and 20 to 25 % of survivors suffering from ...
openaire   +1 more source

Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease

Lancet, The, 1999
Michael Levin
exaly